ExecuPharm Holding Company Inc., a leading, global functional service provider (FSP) serving the biopharmaceutical industry, completed the sale of 100% of its company stock to PAREXEL International Corp., a publicly-traded strategic buyer. Our firm represented ExecuPharm Holding Company in the transaction.
Results may vary depending on your particular facts and legal circumstances.
